Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript
Thanks for joining us. My name is Maury Raycroft and I'm one of the biotech analysts at Jefferies. I'd like to welcome Yvonne Greenstreet, the CEO of Alnylam. Thanks so much for joining us today, Yvonne.
It's a real pleasure to be here and glad to see such a full room. Wonderful. Is my microphone working? Yes.
And we're going to do a fireside chat format. So for those who may be new to the story, maybe give a 1-minute intro to Alnylam and some of the key catalysts coming up in the next 12 to 18 months.
Absolutely. So Alnylam is -- some of you may know, is the leading RNAi company, and we're particularly proud of the fact that we brought to market 4 RNAi therapeutics, actually,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
